Navigation Links
Duane Reade Announces Plans for H1N1 Immunization Program
Date:12/17/2009

NEW YORK, Dec. 17 /PRNewswire/ -- Duane Reade, the largest drug store chain in New York City, today announced plans for its H1N1 immunization program as part of the Company's commitment to meet the health and wellness needs of New Yorkers and to be a destination for their flu related needs.

H1N1 immunization vaccines will be offered at select Duane Reade pharmacies in the near term, pending the release of the H1N1 vaccine by the New York City Department of Health. For the most up-to-date information and exact store locations where New Yorkers can receive the H1N1 vaccination, please visit Duane Reade's website at www.duanereade.com/FluShots.aspx or call the customer service hotline at 1-866-DR-LOYAL (1-866-375-6925). Customers may also sign up to receive mobile alerts that will inform them of specific Duane Reade store locations where the vaccine will be available. Interested parties can simply text "flu" to 63103 and follow the instructions when prompted.

"We are very pleased that we will be able to provide this important public service to New Yorkers," said Frank Scorpiniti, Senior Vice President, Pharmacy Operations. "Duane Reade has long been a health and wellness destination for New Yorkers and we are confident that the recent improvements we have made to our operations better equip us to meet our customers' needs as they face a variety of health concerns, including the H1N1 virus. Moreover, we have developed a strong working relationship with New York City's health officials who recognize Duane Reade as a leading provider of health and wellness services for New Yorkers. This will allow us to procure and administer a sizeable number of vaccines and benefit the community at large."

In December 2008 New York became one of the most recent states to enact laws and regulations permitting pharmacists to administer vaccines. In an effort to adapt quickly and to prepare its organization for the H1N1 immunization program, Duane Reade collaborated with the American Pharmacists Association to certify a large number of its pharmacists to administer the H1N1 vaccine. All of Duane Reade's pharmacists are qualified to consult patients and answer questions about the treatment and prevention of the H1N1 virus and seasonal flu, as well as to discuss influenza warning signs and the proper use of antiviral medications and over-the-counter products to treat influenza or relieve flu symptoms.

In addition to offering the H1N1 immunizations, each of Duane Reade's more than 250 stores locations offer seasonal flu supplies such as alcohol-based hand sanitizers and rubs, thermometers, masks, and other flu-related items. Moreover, Duane Reade's pharmacies are fully stocked with Tamiflu and Relenza. In collaboration with New York City health officials, Duane Reade will offer Tamiflu and Relenza at lower costs to those customers who are uninsured and underinsured.

The cost to receive the H1N1 vaccine is $20. Customers who are New York Medicaid and Medicare beneficiaries can receive influenza immunizations at Duane Reade as a covered benefit. All other customers should speak with their insurance providers to determine if the cost of the vaccine is covered under their individual plans.

About Duane Reade

Founded in 1960, Duane Reade is the largest drug store chain in New York City. In keeping with company's brand vision of New York Living Made Easy, Duane Reade provides New Yorkers with prescriptions, health products and services, beauty products and services, food and convenience items for daily life in the City... everything for "How I Feel", "How I Look", and "What I Need Now". The company operates 250+ stores throughout the metropolitan New York region.



    Media Contact:
    Samantha Cohen
    FD
    (212) 850-5600


SOURCE Duane Reade


'/>"/>
SOURCE Duane Reade
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Juvenile Diabetes Research Foundation to Honor Duane DeSisto of Insulet Corporation and Senator Edward M. Kennedy at 27th Annual Hearts & Heroes Gala
2. Connectyx Announces Distribution Partnership with United States Medical Supply
3. Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 10, 2010
4. Ethicon Announces Definitive Agreement to Acquire Acclarent
5. Boston Scientific Announces Election of Nelda Connors to Its Board of Directors
6. BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronies Disease
7. Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects
8. Cellular Dynamics Announces Commercial Launch of iCell(TM) Cardiomyocytes for Drug Candidate Toxicity Screening
9. Volcano Announces Installed Base Growth Milestone
10. West Announces First Quarter 2010 Dividend
11. Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
Breaking Medicine Technology:
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic ... Frederick area economy by obtaining investment capital for emerging technology companies. SCP ... that have already resulted in more than a million dollars of capital investment ...
(Date:6/24/2016)... ... ... Finally, a bruise cream that really works. Originally designed to reduce ... post-surgical treatment plans of a variety of other procedures including, but not limited to, ... bruising and causes a rapid resolution of bruising and inflammatory changes compared to no ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Dr. Seema Daulat, ... Evans Dermatology in the South Lamar location as of July 13, 2016. , Dr. ... School. As a medical student, she regularly volunteered at the Agape Clinic serving Dallas’ ...
Breaking Medicine News(10 mins):